Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
lüll Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review Freedman AM; Sanyal AJ; Tisnado J; Cole PE; Shiffman ML; Luketic VA; Purdum PP; Darcy MD; Posner MPRadiographics 1993[Nov]; 13 (6): 1185-210It is generally accepted that the transjugular intrahepatic portosystemic shunt (TIPS) procedure has lower morbidity and mortality rates than those of surgical shunting. Nevertheless, complications occur. The authors have reviewed their experience and that of other institutions in compiling an extensive list of complications. Complications are categorized according to those related to transhepatic needle puncture, transvenous access to the portal vein, portal venous cannulation, the stent, the puncture site, portosystemic shunting, and contrast material. Excluding hepatic encephalopathy and delayed stenosis or occlusion of the shunt, an overall complication rate of less than 10% can be expected for TIPS. The prevalence of aggravated or new cases of encephalopathy is 5%-35%, and over the long term, up to 75% of shunts may undergo stenosis or occlusion. The direct procedural mortality rate is less than 2%, and the 30-day mortality rate ranges from 4% to 45%, depending on several factors. The role to which TIPS is relegated will be influenced by the long-term success rate in the prevention of recurrent variceal hemorrhage.|Catheterization, Peripheral/adverse effects[MESH]|Contrast Media/adverse effects[MESH]|Diagnostic Imaging[MESH]|Hemoperitoneum/etiology[MESH]|Humans[MESH]|Portal System/*injuries[MESH]|Portal Vein/*injuries[MESH]|Portasystemic Shunt, Surgical/*adverse effects/methods/mortality[MESH]|Radiology, Interventional[MESH]|Stents/adverse effects[MESH]|Wounds, Penetrating/*etiology[MESH] |